Deep Breeze is a privately held medical device company that is providing
advanced pulmonary imaging with its proprietary patented technology,
Vibration Response Imaging (VRI).
VRI is a non-invasive and radiation-free technology. Based on VRI
technology, Deep Breeze has developed the VRI(XP)(TM), an imaging device
that aids clinicians in their diagnosis and treatment of various lung
conditions. The VRI(XP)(TM) receives vibration response energy generated by
the lungs and translates it into a real-time structural and functional image
of the lungs.
Deep Breeze is currently conducting clinical studies globally, evaluating
VRI(XP)(TM) efficacy in critical care patient management, interventional
pulmonology, and monitoring of asthma, congestive heart failure and lung
Deep Breeze was founded in 2001 and maintains its corporate headquarters,
research and development laboratories, and manufacturing facility in Or-Akiva,
The VRI(XP) is not approved for sale in the United States.